Show Menu

A fully integrated developer and manufacturer of polyclonal therapeutics, targeting infectious disease and acute toxic events

News: Archive for April 2013

MicroPharm Commences Clinical Trial of New Veterinary Antivenom

MicroPharm is pleased to announce that is has recently been granted an Animal Trial Certificate by the Veterinary Medicines Directorate to perform clinical trials on its new veterinary antivenom, ViperaVet, developed for the treatment of dogs envenomed by one of the four medically important species of Vipera (adder) found throughout Western Europe.  

Read the full story

Posted on: Friday, 5th April 2013